Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer

Purpose: To evaluate the oncological outcome after stereotactic body radiation therapy (SBRT) for oligometastatic hormone-sensitive prostate cancer (omHSPC) patients. Materials-Methods: In this retrospective, observational, multi-institutional study, omHSPC patients (≤5 metastases) underwent SBRT. P...

Full description

Bibliographic Details
Main Authors: D. Baron, D. Pasquier, T. Pace-Loscos, B Vandendorpe, R. Schiappa, C. Ortholan, J.M. Hannoun-Levi
Format: Article
Language:English
Published: Elsevier 2023-11-01
Series:Clinical and Translational Radiation Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405630823000988